Regeneron Pharmaceuticals Inc (REGN)

828.82 -14.78 (-1.75%) USD  |  NASDAQ  |  Nov 04, 16:00
830.00 +1.18 (+0.14%) After-Hours: 20:00
More

Regeneron Pharmaceuticals Asset Impairment Charge (Quarterly)

Asset Impairment Charge (Quarterly) Chart

View Asset Impairment Charge (Quarterly) for REGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Asset Impairment Charge (Quarterly) Data

View and export this data back to 2008. Upgrade now.
Date Value
September 30, 2008 --
Date Value
June 30, 2008 --

Asset Impairment Charge Definition

Asset Impairment Charge is a part of the consolidated statement of cash flows, specifically cash flows from operations. Asset impairment charges occur when the market value of a company's asset decreases below its book value. This process is called a writedown.

Read full definition.

Asset Impairment Charge (Quarterly) Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

Asset Impairment Charge (Quarterly) Benchmarks

Amgen Inc --
Eli Lilly and Co --
Pfizer Inc Upgrade
Biogen Inc Upgrade
Vertex Pharmaceuticals Inc --